Small cell prostate cancer: A very rare entity

Year 2021, Volume: 38 Issue: 1, 47 - 50, 26.01.2021

Ayhan Karaköse , Çağatay Arslan , Erkan Şahin , Ragıp Ortaç

Abstract

Small cell prostate cancer which is associated with a high disease specific mortality is a rare disorder accounting for less than 1% of all prostate cancers. We present here a case of 64 years old male patient presented with lower urinary tract symptoms. The prostate needle biopsy result was reported as prostate adenocarcinoma (predominant component small cell carcinoma) Gleason 5 + 3=8 (eight). Chemotherapy and radiotherapy were planned. The patient was asymptomatic 8 months after treatment. He died 13 months after initial diagnosis because of the metastatic lesions.

Keywords

Small cell carcinoma, Prostate cancer, Neuroendocrine differentiation

References

• Walenkamp, A.M., Sonke, G.S., Sleijfer, D.T., 2009. Clinical and therapeutic aspects of extrapulmonary small cell carcinoma.Cancer Treat Rev. May;35(3):228-36. doi: 10.1016/j.ctrv.2008.10.007. Epub 2008 Dec 9.
• Demirtaş, A., Şahin, N., Öztürk, F., Akınsal, E.C., Demirtaş, T., Ekmekcioğlu, O., Tatlışen, A., 2013. Small Cell Prostate Carcinoma: A Case Report and Review of the Literature. Case Rep Urol. 2013: 387931doi: 10.1155/2013/387931
• Weprin, S., Yonover, P., 2017. Small Cell Carcinoma of the Prostate: A Case Report and Brief Review of the Literature.Urol Case Rep. Apr 26;13:61-62. doi: 10.1016/j.eucr.2016.10.010. eCollection 2017 Jul.
• Wenk, R.E., Bhagavan, B.S., Levy, R., Miller, D., Weisburger, W., 1977. Ectopic ACTH, prostatic oat cell carcinoma, and marked hypernatremia.Cancer. Aug;40(2):773-8.
• Spiess, P.E., Pettaway, C.A., Vakar-Lopez, F., Kassouf, W., Wang, X., Busby, J.E., Do, K.A., Davuluri, R., Tannir, N.M., 2007. Treatment outcomes of small cell carcinoma of the prostate: a single-center study. Cancer. Oct 15;110(8):1729-37.
• Petraki, C., Vaslamatzis, M., Petraki, K., Revelos, K., Alevizopoulos, N., Papanastasiou, P., Gregorakis, A., 2005. Prostatecancer with small-cell morphology: an immunophenotypic subdivision. Scand J Urol Nephrol 39:455–463.
• Palmgren, J.S., Karavadia, S.S., Wakefield, M.R., 2007. Unusual and underappreciated: small cell carcinoma of the prostate. Semin Oncol 34:22–29.
• Papandreou, C.N., Daliani, D.D., Thall, P.F., Tu, S.M., Wang, X., Reyes, A., Troncoso, P., Logothetis, C.J., 2002. Results of aphase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate. J Clin Oncol 20:3072–3080.
• Erasmus, C.E., Verhagen, W.I., Wauters, C.A., vanLindert, E.J., 2002. Brain metastasis from prostate small cell carcinoma: Not to be neglected. Can J Neurol Sci. 29:375.
• Deorah, S., Rao, M.B., Raman, R., Gaitonde, K., Donovan, J.F., 2012. Survival of patients with small cell carcinoma of the prostate during 1973-2003: A population-based study. BJU Int. 109:824.
• Capizzello, A., Peponi, E., Simou, N., Ntaskagiannis, D., Tasiou, I., Kamina, S., Tsekeris, P., 2001. Pure small cell carcinoma of the prostate: a case report and literature review. Case Rep Oncol. Feb 16;4(1):88-95. doi: 10.1159/000324717.
• Asmis, T.R., Reaume, M.N., Dahrouge, S., Malone, S., 2006. Genitourinary small cell carcinoma: a retrospective review of treatment and survival patterns at The Ottawa Hospital Regional Cancer Center. BJU Int. Apr;97(4):711-5.
• Hindson, D.A., Knight, L.L., Ocker, J.M., 1985. Small-cell carcinoma of prostate. Transient complete remission with chemotherapy. Urology. Aug;26(2):182-4.
• Brammer, J.E., Lulla, P., Lynch, G.R., 2011.Complete remission in a patient with metastatic mixed adenocarcinoma/extrapulmonary small cell carcinoma of the prostate. Int J ClinOncol. Dec;16(6):722-5. doi: 10.1007/s10147-011-0198-2. Epub 2011 Feb 24.